| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $42,167,374 ) (Continued on the next page) |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI175428 | mRNA-encoded Cas13 as a pan-respiratory antiviral | 000 | 4 | NIH | 1/14/2026 | $709,376 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG097853 | Improving Residual Sleepiness and Inflammation in Older Adults with OSA: An RCT of Citicoline | 000 | 1 | NIH | 2/4/2026 | $494,109 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI072435 | Characterization of Lamprey B cells and Antibodies | 000 | 19 | NIH | 12/4/2025 | $536,005 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG092720 | The Role of PML in Oxidative Stress and Alzheimer's Disease | 000 | 1 | NIH | 2/3/2026 | $651,466 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG093890 | Testing Cognitive Behavioral Therapy for Insomnia (CBT-I) on Dyadic Sleep in Dementia: A Randomized Control Trial | 000 | 1 | NIH | 2/3/2026 | $627,646 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG094161 | Poly (ADP-ribose) polymerase ligand discovery for Alzheimer's disease | 000 | 2 | NIH | 12/26/2025 | $702,682 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG093923 | Defining Pathological Roles of Novel Protein Interactions with Amyloid in Alzheimer's Disease | 000 | 1 | NIH | 2/3/2026 | $657,222 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R00HL166700 | Investigating relationships between naturalistic light exposure and sleep | 000 | 3 | NIH | 2/2/2026 | $248,705 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01GM144729 | Acylations: a novel pathway in the response to mitochondrial energy dysfunction | 000 | 5 | NIH | 12/22/2025 | $281,700 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01GM144563 | Actin regulation by cyclase-associated protein | 000 | 3 | NIH | 12/9/2025 | $281,700 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DE033433 | Targeted Arf1 inhibition to enhance immune response in oral cancer | 000 | 3 | NIH | 1/26/2026 | $334,714 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DK131189 | Rapid quantitative renal fibrosis evaluation with dual-mode microscopy | 000 | 5 | NIH | 12/18/2025 | $504,172 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DK134509 | Adult epigenetics and telomere length in relation to improved nutrition in early life | 000 | 4 | NIH | 2/11/2026 | $629,499 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01ES032440 | Interaction of Pyrethroid Exposure and the Microbiome on Parkinson's Disease related Pathologies | 000 | 5 | NIH | 12/22/2025 | $346,685 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01ES027859 | Mechanisms of transgenerational epigenetic inheritance | 000 | 9 | NIH | 1/1/2026 | $503,096 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DK136023 | Developing statistical analysis and prediction tools for continuous glucose monitoring (CGM) use in hospitalized patients with diabetes | 000 | 3 | NIH | 1/24/2026 | $402,562 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DK139326 | Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation (CARE-D-Foot-Nav), a randomized controlled trial | 000 | 2 | NIH | 1/29/2026 | $552,988 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DK146067 | Putting Phenotypes and Polygenics into Practice for Diabetes Care (4PDC) | 000 | 1 | NIH | 2/3/2026 | $824,296 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01NS132884 | ATIC is a novel molecular target in diffuse intrinsic pontine glioma | 000 | 3 | NIH | 12/12/2025 | $373,226 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01NS146992 | Understanding the contribution of BCL11A to neuron function and neurological disease | 000 | 1 | NIH | 1/27/2026 | $575,485 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01NS134941 | The Pallidohabenular System in Parkinsonism | 000 | 3 | NIH | 1/15/2026 | $445,676 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01NS140219 | Contribution of cell-specific activity to functional MRI | 000 | 1 | NIH | 1/23/2026 | $577,611 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA287866 | Leveraging CD26high Meso-CAR T cells in patients with advanced pancreatic cancer | 000 | 3 | NIH | 2/9/2026 | $575,037 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA276135 | Discovery of a novel MDM2-tubulin signaling pathway as a therapeutic target in AML | 000 | 3 | NIH | 12/10/2025 | $482,689 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA281148 | Targeting PGC1β/PPARγ axis for overcoming acquired resistant to third generation EGFR-TKIs | 000 | 3 | NIH | 12/11/2025 | $436,031 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA277686 | Dissecting and targeting oncogenic functions of PAK4 in high-risk rhabdomyosarcoma | 000 | 4 | NIH | 12/22/2025 | $320,831 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA275964 | Targeting leukemic stem cells in acute myeloid leukemia | 000 | 4 | NIH | 12/19/2025 | $379,944 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA295722 | Racial Disparities in the Mechanisms of Prostate Cancer Metastasis | 000 | 2 | NIH | 12/17/2025 | $573,468 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA289761 | Functional consequences of SMARCB1 variants | 000 | 2 | NIH | 12/15/2025 | $470,970 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DC021478 | Dissecting the first layer of central taste processing in Drosophila | 001 | 3 | NIH | 2/10/2026 | $37,795 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DC020749 | Advancing primate models of human auditory cognitive control | 001 | 4 | NIH | 2/10/2026 | $45,017 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DC021478 | Dissecting the first layer of central taste processing in Drosophila | 000 | 3 | NIH | 11/21/2025 | $340,158 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DC020749 | Advancing primate models of human auditory cognitive control | 000 | 4 | NIH | 12/5/2025 | $405,157 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DC013066 | Planar Polarity Mechanisms in Mammalian Inner Ear Development | 001 | 14 | NIH | 2/10/2026 | $50,226 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DC013066 | Planar Polarity Mechanisms in Mammalian Inner Ear Development | 000 | 14 | NIH | 1/16/2026 | $452,031 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35GM148416 | Genetic Dissection of Signaling and Cilia | 001 | 4 | NIH | 1/14/2026 | $82,045 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35GM148416 | Genetic Dissection of Signaling and Cilia | 000 | 4 | NIH | 1/7/2026 | $405,361 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35GM148217 | The Gut as a Target to Improve Outcomes in Sepsis | 000 | 4 | NIH | 12/15/2025 | $478,890 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R37MH117103 | Integrated mechanisms for orbitofrontal cortical control of memory and choice | 000 | 8 | NIH | 1/13/2026 | $666,266 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35GM156739 | Lipoprotein trafficking to the bacterial outer membrane | 000 | 2 | NIH | 12/12/2025 | $391,145 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21NS142817 | Neuromodulation of somato-sympathetic postganglionic activity after SCI | 000 | 1 | NIH | 1/26/2026 | $234,750 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21TW012879 | GROW: Adapting and Enhancing Group-based Prenatal Care to Support Healthy Gestational Weight Gain for HIV-affected Women | 000 | 1 | NIH | 2/13/2026 | $92,281 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R24ES028507 | Enriching the Rhode Island Child Health Study | 000 | 9 | NIH | 2/13/2026 | $494,162 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01MH133798 | Actin Cytoskeleton in Postsynaptic Structure and Function | 000 | 3 | NIH | 1/6/2026 | $548,622 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01MH131910 | Targeting Inflammation-Induced Changes in Brain Reward Signaling and Motivational Deficits in Patients with Schizophrenia Using an Anti-Inflammatory Challenge | 000 | 4 | NIH | 12/19/2025 | $585,197 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01MH128130 | STI Response and Recommendations Under PrEP (STIRRUP) | 000 | 5 | NIH | 1/7/2026 | $610,138 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01MH133612 | Elucidating the Signaling Landscapes Underlying Cellular and Regional Specification During Human Brain Development | 000 | 3 | NIH | 11/26/2025 | $760,493 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01MH130755 | Prefrontal circuits in processing social versus non-social rewards | 000 | 4 | NIH | 1/14/2026 | $377,953 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01NS125768 | A Conserved RNA Binding Protein Required for Control of Key Developmental Pathways | 000 | 5 | NIH | 2/5/2026 | $341,245 |
|
